IO Biotech Ownership 2024 | Who Owns IO Biotech Now?

Overview RevenueFinancials Chart

Institutional Ownership

0.33%

Insider Ownership

0.24%

Retail Ownership

99.43%

Institutional Holders

3.00

IO Biotech Institutional Shareholders

Institutional Shareholders by % of Total Shares

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
VIVO CAPITAL, LLC	9.37%	0.67%	6,173,439	-	-	7,222,924	Jun 30, 2024
NOVO HOLDINGS A/S	6.72%	0.30%	4,429,449	-658,809	-12.95%	5,182,455	Jun 30, 2024
SAMSARA BIOCAPITAL, LLC	5.53%	0.89%	3,640,015	-	-	4,258,818	Jun 30, 2024
PFM HEALTH SCIENCES, LP	3.55%	0.14%	2,341,107	-	-	2,739,095	Jun 30, 2024
MARSHALL WACE, LLP	3.20%	0.00%	2,105,262	-	-	2,463,156	Jun 30, 2024
MORGAN STANLEY	2.99%	0.00%	1,972,343	-224,891	-10.24%	2,307,641	Jun 30, 2024
BANK OF AMERICA CORP /DE/	2.51%	0.00%	1,651,515	-192,670	-10.45%	1,932,273	Jun 30, 2024
ARMISTICE CAPITAL, LLC	2.35%	0.02%	1,545,000	-179,000	-10.38%	1,807,650	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.50%	0.01%	987,654	-	-	1,155,555	Jun 30, 2024
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC	1.31%	0.78%	864,197	-	-	1,011,110	Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP	0.75%	0.05%	493,827	-	-	577,778	Jun 30, 2024
FMR LLC	0.48%	-	314,600	-	-	368,082	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	0.29%	0.02%	192,670	192,670	100.00%	225,424	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.27%	0.00%	180,800	13,600	8.13%	211,536	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.19%	0.00%	124,623	-	-	145,809	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.05%	-	33,307	-	-	38,969	Jun 30, 2024
XTX TOPCO LTD	0.04%	0.00%	26,555	10,688	67.36%	31,069	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.01%	0.00%	4,166	4,166	100.00%	4,874	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,280	3,280	100.00%	3,838	Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	-	-	-	-156,167	-100.00%	-	Jun 30, 2024

IO Biotech's largest institutional shareholder is VIVO CAPITAL, LLC, holding 9.37% of the company's total share outstanding, currently valued at $7.22M. The top 10 institutional shareholders own together 39.02% of the company.

Institutional Shareholders by % of Total Assets

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SAMSARA BIOCAPITAL, LLC	5.53%	0.89%	3,640,015	-	-	4,258,818	Jun 30, 2024
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC	1.31%	0.78%	864,197	-	-	1,011,110	Jun 30, 2024
VIVO CAPITAL, LLC	9.37%	0.67%	6,173,439	-	-	7,222,924	Jun 30, 2024
NOVO HOLDINGS A/S	6.72%	0.30%	4,429,449	-658,809	-12.95%	5,182,455	Jun 30, 2024
PFM HEALTH SCIENCES, LP	3.55%	0.14%	2,341,107	-	-	2,739,095	Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP	0.75%	0.05%	493,827	-	-	577,778	Jun 30, 2024
ARMISTICE CAPITAL, LLC	2.35%	0.02%	1,545,000	-179,000	-10.38%	1,807,650	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	0.29%	0.02%	192,670	192,670	100.00%	225,424	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.50%	0.01%	987,654	-	-	1,155,555	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.01%	0.00%	4,166	4,166	100.00%	4,874	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.19%	0.00%	124,623	-	-	145,809	Jun 30, 2024
MARSHALL WACE, LLP	3.20%	0.00%	2,105,262	-	-	2,463,156	Jun 30, 2024
XTX TOPCO LTD	0.04%	0.00%	26,555	10,688	67.36%	31,069	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.27%	0.00%	180,800	13,600	8.13%	211,536	Jun 30, 2024
MORGAN STANLEY	2.99%	0.00%	1,972,343	-224,891	-10.24%	2,307,641	Jun 30, 2024
BANK OF AMERICA CORP /DE/	2.51%	0.00%	1,651,515	-192,670	-10.45%	1,932,273	Jun 30, 2024
FMR LLC	0.48%	-	314,600	-	-	368,082	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.05%	-	33,307	-	-	38,969	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,280	3,280	100.00%	3,838	Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	-	-	-	-156,167	-100.00%	-	Jun 30, 2024

The largest IO Biotech shareholder by % of total assets is SAMSARA BIOCAPITAL, LLC. The company owns 3.64M shares of IO Biotech (IOBT), representing 0.89% of its total assets.

Institutional Buyers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SOLEUS CAPITAL MANAGEMENT, L.P.	0.29%	0.02%	192,670	192,670	100.00%	225,424	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.27%	0.00%	180,800	13,600	8.13%	211,536	Jun 30, 2024
XTX TOPCO LTD	0.04%	0.00%	26,555	10,688	67.36%	31,069	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.01%	0.00%	4,166	4,166	100.00%	4,874	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,280	3,280	100.00%	3,838	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.05%	-	33,307	-	-	38,969	Jun 30, 2024
FMR LLC	0.48%	-	314,600	-	-	368,082	Jun 30, 2024
MARSHALL WACE, LLP	3.20%	0.00%	2,105,262	-	-	2,463,156	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.19%	0.00%	124,623	-	-	145,809	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.50%	0.01%	987,654	-	-	1,155,555	Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP	0.75%	0.05%	493,827	-	-	577,778	Jun 30, 2024
PFM HEALTH SCIENCES, LP	3.55%	0.14%	2,341,107	-	-	2,739,095	Jun 30, 2024
VIVO CAPITAL, LLC	9.37%	0.67%	6,173,439	-	-	7,222,924	Jun 30, 2024
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC	1.31%	0.78%	864,197	-	-	1,011,110	Jun 30, 2024
SAMSARA BIOCAPITAL, LLC	5.53%	0.89%	3,640,015	-	-	4,258,818	Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	-	-	-	-156,167	-100.00%	-	Jun 30, 2024
ARMISTICE CAPITAL, LLC	2.35%	0.02%	1,545,000	-179,000	-10.38%	1,807,650	Jun 30, 2024
BANK OF AMERICA CORP /DE/	2.51%	0.00%	1,651,515	-192,670	-10.45%	1,932,273	Jun 30, 2024
MORGAN STANLEY	2.99%	0.00%	1,972,343	-224,891	-10.24%	2,307,641	Jun 30, 2024
NOVO HOLDINGS A/S	6.72%	0.30%	4,429,449	-658,809	-12.95%	5,182,455	Jun 30, 2024

As of Jun 30 2024, IO Biotech's largest institutional buyer is SOLEUS CAPITAL MANAGEMENT, L.P.. The company purchased 192.67K stocks of IOBT, valued at $225.42K.

Institutional Sellers

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
NOVO HOLDINGS A/S	6.72%	0.30%	4,429,449	-658,809	-12.95%	5,182,455	Jun 30, 2024
MORGAN STANLEY	2.99%	0.00%	1,972,343	-224,891	-10.24%	2,307,641	Jun 30, 2024
BANK OF AMERICA CORP /DE/	2.51%	0.00%	1,651,515	-192,670	-10.45%	1,932,273	Jun 30, 2024
ARMISTICE CAPITAL, LLC	2.35%	0.02%	1,545,000	-179,000	-10.38%	1,807,650	Jun 30, 2024
STONEPINE CAPITAL MANAGEMENT, LLC	-	-	-	-156,167	-100.00%	-	Jun 30, 2024
SAMSARA BIOCAPITAL, LLC	5.53%	0.89%	3,640,015	-	-	4,258,818	Jun 30, 2024
PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC	1.31%	0.78%	864,197	-	-	1,011,110	Jun 30, 2024
VIVO CAPITAL, LLC	9.37%	0.67%	6,173,439	-	-	7,222,924	Jun 30, 2024
PFM HEALTH SCIENCES, LP	3.55%	0.14%	2,341,107	-	-	2,739,095	Jun 30, 2024
LOGOS GLOBAL MANAGEMENT LP	0.75%	0.05%	493,827	-	-	577,778	Jun 30, 2024
ALYESKA INVESTMENT GROUP, L.P.	1.50%	0.01%	987,654	-	-	1,155,555	Jun 30, 2024
BRIDGEWAY CAPITAL MANAGEMENT, LLC	0.19%	0.00%	124,623	-	-	145,809	Jun 30, 2024
MARSHALL WACE, LLP	3.20%	0.00%	2,105,262	-	-	2,463,156	Jun 30, 2024
FMR LLC	0.48%	-	314,600	-	-	368,082	Jun 30, 2024
GEODE CAPITAL MANAGEMENT, LLC	0.05%	-	33,307	-	-	38,969	Jun 30, 2024
UBS GROUP AG	0.01%	-	3,280	3,280	100.00%	3,838	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.01%	0.00%	4,166	4,166	100.00%	4,874	Jun 30, 2024
XTX TOPCO LTD	0.04%	0.00%	26,555	10,688	67.36%	31,069	Jun 30, 2024
RENAISSANCE TECHNOLOGIES LLC	0.27%	0.00%	180,800	13,600	8.13%	211,536	Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.	0.29%	0.02%	192,670	192,670	100.00%	225,424	Jun 30, 2024

As of Jun 30 2024, IO Biotech's biggest institutional seller is NOVO HOLDINGS A/S. The company sold -0.66M shares of IOBT, valued at $5.18M.

Institutional New positions

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
SOLEUS CAPITAL MANAGEMENT, L.P.	0.29%	0.02%	192,670	192,670	100.00%	225,424	Jun 30, 2024
REDWOOD WEALTH MANAGEMENT GROUP, LLC	0.01%	0.00%	4,166	4,166	100.00%	4,874	Jun 30, 2024

IO Biotech's largest new institutional shareholder by number of shares is SOLEUS CAPITAL MANAGEMENT, L.P., purchased 192.67K shares, valued at $225.42K, as of undefined.

Institutional Sold Out

Name	% Total Shares	% Total Assets	Current Shares	Change Amount	Change %	Market Value	Date
STONEPINE CAPITAL MANAGEMENT, LLC	-	-	-	-156,167	-100.00%	-	Jun 30, 2024

IO Biotech's largest sold out institutional shareholder by shares sold is STONEPINE CAPITAL MANAGEMENT, LLC, sold -0.16M shares, valued at -, as of undefined.

IO Biotech Mutual Fund Holders

Name	% Total Assets	Total Shares	Change Amount	Change %	Date
BRIDGEWAY FUNDS INC	0.05%	124,000	-21,200	-14.60%	Mar 28, 2024
SMALLCAP WORLD FUND INC	0.01%	419,714	-	-	Mar 31, 2024
USAA MUTUAL FUNDS TRUST	0.00%	40,174	-	-	Jan 31, 2024
VANGUARD INDEX FUNDS	0.00%	62,234	-	-	Mar 31, 2024
FIDELITY CONCORD STREET TRUST	0.00%	25,040	12,310	96.70%	Feb 29, 2024
VICTORY PORTFOLIOS	0.00%	3,567	-	-	Mar 31, 2024

IO Biotech's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 124.00K shares, compromising 0.05% of its total assets.

IO Biotech Institutional Ownership Trends

Institutional Holdings Trend

Date	Holdings	Change %
30 Jun, 24	3	-83.33%
31 Mar, 24	18	-5.26%
31 Dec, 23	19	-5.00%
30 Sep, 23	20	33.33%
30 Jun, 23	15	-11.76%
31 Mar, 23	17	-
31 Dec, 22	17	-15.00%
30 Sep, 22	20	11.11%
30 Jun, 22	18	-5.26%
31 Mar, 22	19	-5.00%
31 Dec, 21	20	-

As of 30 Jun 24, 3 institutions are holding IO Biotech's shares, representing a decrease of -83.33% compared to the previous quarter.

Shares Outstanding Trend

Date	Shares Outstanding	Change %
30 Jun, 24	218,273	-99.20%
31 Mar, 24	27,341,910	-7.00%
31 Dec, 23	29,400,721	-0.90%
30 Sep, 23	29,668,665	142.26%
30 Jun, 23	12,246,779	-12.00%
31 Mar, 23	13,917,553	-2.55%
31 Dec, 22	14,281,285	-6.87%
30 Sep, 22	15,335,530	-0.76%
30 Jun, 22	15,453,557	4.00%
31 Mar, 22	14,858,855	-1.19%
31 Dec, 21	15,038,466	-

IO Biotech (IOBT) has 218.27K shares outstanding as of 30 Jun 24, down -99.20% compared to the previous quarter.

Institutional Ownership Trend

Date	Ownership %	Change %
30 Jun, 24	0.33%	0.01%
31 Mar, 24	62.80%	1.83%
31 Dec, 23	58.60%	0.55%
30 Sep, 23	102.96%	5.70%
30 Jun, 23	42.50%	1.82%
31 Mar, 23	48.30%	1.97%
31 Dec, 22	49.56%	1.75%
30 Sep, 22	53.22%	1.85%
30 Jun, 22	53.63%	2.02%
31 Mar, 22	51.57%	1.51%
31 Dec, 21	58.45%	-

As of 30 Jun 24, IO Biotech is held by 0.33% institutional shareholders, representing a 0.01% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

Date	Increased Positions	Change %
30 Jun, 24	2	-60.00%
31 Mar, 24	5	-28.57%
31 Dec, 23	7	-41.67%
30 Sep, 23	12	100.00%
30 Jun, 23	6	50.00%
31 Mar, 23	4	-
31 Dec, 22	4	-50.00%
30 Sep, 22	8	-
30 Jun, 22	8	33.33%
31 Mar, 22	6	-70.00%
31 Dec, 21	20	-

2 institutional shareholders have increased their position in IOBT stock as of 30 Jun 24 compared to 5 in the previous quarter (a -60.00% decrease).

Institutional Reduced Positions Trend

Date	Reduced Positions	Change %
30 Jun, 24	-	-100.00%
31 Mar, 24	5	25.00%
31 Dec, 23	4	100.00%
30 Sep, 23	2	100.00%
30 Jun, 23	1	-66.67%
31 Mar, 23	3	-40.00%
31 Dec, 22	5	66.67%
30 Sep, 22	3	-
30 Jun, 22	3	50.00%
31 Mar, 22	2	-
31 Dec, 21	-	-

- institutional shareholders have reduced their position in IOBT stock as of 30 Jun 24 compared to 5 in the previous quarter (a -100.00% decrease).

All Institutional Ownership Trend Data

Date	Holdings	Change %	Shares Outstanding	Change %	Ownership %	Change %	Increased Positions	Change %	Reduced Positions	Change %
30 Jun, 24	3	-83.33%	218,273	-99.20%	0.33%	0.01%	2	-60.00%	-	-100.00%
31 Mar, 24	18	-5.26%	27,341,910	-7.00%	62.80%	1.83%	5	-28.57%	5	25.00%
31 Dec, 23	19	-5.00%	29,400,721	-0.90%	58.60%	0.55%	7	-41.67%	4	100.00%
30 Sep, 23	20	33.33%	29,668,665	142.26%	102.96%	5.70%	12	100.00%	2	100.00%
30 Jun, 23	15	-11.76%	12,246,779	-12.00%	42.50%	1.82%	6	50.00%	1	-66.67%
31 Mar, 23	17	-	13,917,553	-2.55%	48.30%	1.97%	4	-	3	-40.00%
31 Dec, 22	17	-15.00%	14,281,285	-6.87%	49.56%	1.75%	4	-50.00%	5	66.67%
30 Sep, 22	20	11.11%	15,335,530	-0.76%	53.22%	1.85%	8	-	3	-
30 Jun, 22	18	-5.26%	15,453,557	4.00%	53.63%	2.02%	8	33.33%	3	50.00%
31 Mar, 22	19	-5.00%	14,858,855	-1.19%	51.57%	1.51%	6	-70.00%	2	-
31 Dec, 21	20	-	15,038,466	-	58.45%	-	20	-	-	-

IO Biotech Insider Shareholders Trades

Open Market Insider Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	51,522	$1.33	$68.34K	4,377,927
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	23,478	$1.31	$30.79K	4,354,449
May 14, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.22	$802.50K	4,429,449
Feb 13, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.50	$988.41K	5,088,258
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$1.03	$5.17K	11,500
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$0.99	$4.95K	6,500

Open Market Insider Buys

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held	Source
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$1.03	$5.17K	11,500
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$0.99	$4.95K	6,500

Insider Sells

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	51,522	$1.33	$68.34K	4,377,927
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	23,478	$1.31	$30.79K	4,354,449
May 14, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.22	$802.50K	4,429,449
Feb 13, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.50	$988.41K	5,088,258

All Insider Owners Trades

Date	Name	Relation	Role	Transaction	Buy/Sell	Shares	Price	Value	Shares Held
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	51,522	$1.33	$68.34K	4,377,927
Jul 26, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	23,478	$1.31	$30.79K	4,354,449
Jun 07, 2024	Smith David V	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
Jun 07, 2024	Hunter Heidi	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
Jun 07, 2024	Hirth Peter	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
Jun 07, 2024	Glaub Kathleen Sereda	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
Jun 07, 2024	Elling Christian E	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
Jun 07, 2024	Collins Helen Louise	director	-	A-Award	Buy	45,642	$1.25	$57.05K	45,642
May 14, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.22	$802.50K	4,429,449
Mar 18, 2024	Zocca Mai-Britt	director, officer	Chief Executive Officer	A-Award	Buy	750,000	$1.65	$1.24M	750,000
Mar 18, 2024	Sullivan Amy	officer	Chief Financial Officer	A-Award	Buy	280,000	$1.65	$462.00K	280,000
Mar 18, 2024	Smith Devin Whittemore	officer	General Counsel	A-Award	Buy	185,000	$1.65	$305.25K	185,000
Mar 18, 2024	Burkavage Brian	officer	Chief Accounting Officer	A-Award	Buy	50,000	$1.65	$82.50K	50,000
Mar 18, 2024	Ahmad Qasim Iftikhar	officer	Chief Medical Officer	A-Award	Buy	280,000	$1.65	$462.00K	280,000
Feb 13, 2024	Novo Holdings A/S	10 percent owner	-	S-Sale	Sell	658,809	$1.50	$988.41K	5,088,258
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$1.03	$5.17K	11,500
Nov 24, 2023	Burkavage Brian	officer	Chief Accounting Officer	P-Purchase	Buy	5,000	$0.99	$4.95K	6,500
Nov 17, 2023	Collins Helen Louise	director	-	A-Award	Buy	64,238	$0.98	$62.95K	64,238
Nov 17, 2023	Collins Helen Louise		-		Buy	-	-	-	-
Aug 21, 2023	Kurma Partners	10 percent owner	-		Buy	-	-	-	4,345,679

The last insider sell of IO Biotech's stock was made by Novo Holdings A/S on Jul 26 2024, selling 51,522 shares at $1.33 per share (valued at $68.34K). The last insider buy of IOBT was made by Burkavage Brian on Nov 24 2023, buying 5,000 shares at $1.03 per share (worth $5.17K).

IO Biotech Insider Ownership Trends

All Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	2	-
Q2 2024	6	1	600.00%
Q1 2024	5	1	500.00%
Q4 2023	3	-	-
Q3 2023	16	-	-
Q2 2023	5	-	-
Q1 2023	2	-	-
Q4 2022	1	-	-
Q2 2022	8	2	400.00%
Q1 2022	1	-	-
Q4 2021	23	34	67.65%

0 total buy trades, and 2 total sell trades (buy/sell ratio of 0.00%) were made by IO Biotech's insiders, as of Q3 2024.

Open Market Insider Trades Trend

Date	Buy	Sell	Buy/Sell Ratio
Q3 2024	-	2	-
Q2 2024	-	1	-
Q1 2024	-	1	-
Q4 2023	2	-	-
Q3 2023	4	-	-
Q2 2023	-	-	-
Q1 2023	1	-	-
Q4 2022	-	-	-
Q2 2022	-	-	-
Q1 2022	-	-	-
Q4 2021	8	-	-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of IO Biotech's stocks.

IO Biotech Peer Ownership

Ticker	Company
PMVP	PMV Pharmaceuticals, Inc.
CGEM	Cullinan Oncology, Inc.
IVA	Inventiva S.A.
IKNA	Ikena Oncology, Inc.
STOK	Stoke Therapeutics, Inc.
IPSC	Century Therapeutics, Inc.
ERAS	Erasca, Inc.
CSBR	Champions Oncology, Inc.
ASLN	ASLAN Pharmaceuticals Limited
GLUE	Monte Rosa Therapeutics, Inc.
MNOV	MediciNova, Inc.
DSGN	Design Therapeutics, Inc.
PHVS	Pharvaris N.V.
GPCR	Structure Therapeutics Inc.
NAMS	NewAmsterdam Pharma Company N.V.
HOWL	Werewolf Therapeutics, Inc.
PEPG	PepGen Inc.
LYRA	Lyra Therapeutics, Inc.
PRDS	Pardes Biosciences, Inc.
CMPX	Compass Therapeutics, Inc.
STTK	Shattuck Labs, Inc.
ELYM	Eliem Therapeutics, Inc.

IOBT Ownership FAQ

Who Owns IO Biotech?

IO Biotech is owned by institutional shareholders (0.33%), insiders (0.24%), and public (99.43%). The largest institutional shareholder of IO Biotech is VIVO CAPITAL, LLC (9.37% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.05% of total shares).

Who are the major institutional shareholders of IO Biotech?

IO Biotech's major institutional shareholders are VIVO CAPITAL, LLC, NOVO HOLDINGS A/S, SAMSARA BIOCAPITAL, LLC, PFM HEALTH SCIENCES, LP, and MARSHALL WACE, LLP. The top five shareholders own together 28.37% of the company's share outstanding.

How many IO Biotech shareholders are there?

As of Jun 2024, there are 3 institutional shareholders of IO Biotech.

What percentage of IO Biotech is owned by VIVO CAPITAL, LLC?

VIVO CAPITAL, LLC owns 6.17M shares of IO Biotech, representing 9.37% of the company's total shares outstanding, valued at $7.22M (as of Jun 2024).

What percentage of IO Biotech is owned by NOVO HOLDINGS A/S?

As of Jun 2024, NOVO HOLDINGS A/S holds 4.43M shares of IO Biotech (IOBT), compromising 6.72% of the company, valued at $5.18M.

What percentage of IO Biotech is owned by SAMSARA BIOCAPITAL, LLC?

SAMSARA BIOCAPITAL, LLC is the third largest holder of IO Biotech. The company owns 3.64M of the company's shares outstanding (worth $4.26M).